NEOG Stock Overview
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for NEOG from our risk checks.
Neogen Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$19.31 |
| 52 Week High | US$24.10 |
| 52 Week Low | US$10.49 |
| Beta | 1.04 |
| 1 Month Change | -14.06% |
| 3 Month Change | -10.97% |
| 1 Year Change | 28.99% |
| 3 Year Change | -47.51% |
| 5 Year Change | -45.22% |
| Change since IPO | 7,455.96% |
Recent News & Updates
Recent updates
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12
Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Neogen: Safety Food Giant In The Making
Dec 15Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Dec 12Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Sep 12Robust Valuation Leaves Neogen Little Room For Error After Mixed Results
Jul 27There Are Reasons To Feel Uneasy About Neogen's (NASDAQ:NEOG) Returns On Capital
Jun 10We're Watching These Trends At Neogen (NASDAQ:NEOG)
Mar 09Neogen Corporation's (NASDAQ:NEOG) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 16Need To Know: Neogen Corporation (NASDAQ:NEOG) Insiders Have Been Selling Shares
Jan 29How Is Neogen's (NASDAQ:NEOG) CEO Compensated?
Jan 11Neogen acquires Ireland-based food quality diagnostic company
Jan 04Neogen Corporation (NASDAQ:NEOG) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Dec 25
Shareholder Returns
| NEOG | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -9.4% | -2.0% | -1.5% |
| 1Y | 29.0% | 5.9% | 13.8% |
Return vs Industry: NEOG exceeded the US Medical Equipment industry which returned 5.9% over the past year.
Return vs Market: NEOG exceeded the US Market which returned 13.8% over the past year.
Price Volatility
| NEOG volatility | |
|---|---|
| NEOG Average Weekly Movement | 5.6% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in US Market | 14.3% |
| 10% least volatile stocks in US Market | 2.5% |
Stable Share Price: NEOG is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: NEOG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 2,640 | John Adent | https://www.neogen.com |
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Neogen Corporation Fundamentals Summary
| NEOG fundamental statistics | |
|---|---|
| Market Cap | US$4.30b |
| Earnings (TTM) | -US$22.87m |
| Revenue (TTM) | US$822.45m |
5.1x
P/S Ratio-182.6x
P/E RatioIs NEOG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEOG income statement (TTM) | |
|---|---|
| Revenue | US$822.45m |
| Cost of Revenue | US$413.25m |
| Gross Profit | US$409.20m |
| Other Expenses | US$432.07m |
| Earnings | -US$22.87m |
Last Reported Earnings
May 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 49.75% |
| Net Profit Margin | -2.78% |
| Debt/Equity Ratio | 28.4% |
How did NEOG perform over the long term?
See historical performance and comparison